Is Epizyme Inc (EPZM) a Good Buy in the Biotechnology Industry?

Tuesday, June 28, 2022 11:27 AM | InvestorsObserver Analysts

Mentioned in this article

The 87 rating InvestorsObserver gives to Epizyme Inc (EPZM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, EPZM’s 87 overall rating means the stock scores better than 87 percent of all stocks.

EPZM has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on EPZM!
See Full EPZM Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 87 means the stock is more attractive than 87 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Epizyme Inc Stock Today?

Epizyme Inc (EPZM) stock is trading at $1.47 as of 11:27 AM on Tuesday, Jun 28, a loss of -$0.01, or -0.68% from the previous closing price of $1.48. The stock has traded between $1.46 and $1.48 so far today. Volume today is below average. So far 2,581,858 shares have traded compared to average volume of 4,386,390 shares. Click Here to get the full Stock Report for Epizyme Inc stock.

Share this article:

Related Articles